Eye on Ocular Health

ReachMD
  • 5.0 (1)
  • SCIENCE

Eye on Ocular Health features expert commentary on the management and prevention of debilitating eye problems, such as age-related macular degeneration, diabetic retinopathy, ocular traumas, and chronic dry eye. This series features commentary from renowned ophthalmologists discussing the most successful diagnostic and treatment options emerging in practice.

  1. 10/14/2025

    Cleaner Air, Clearer Vision: Uncovering Air Pollution’s Role in Childhood Myopia

    Emerging evidence reveals that air pollution may be an overlooked contributor to worsening uncorrected visual acuity in children. In this AudioAbstract, Ryan Quigley explores a large machine learning–based study examining nearly 30,000 East Asian students that revealed lower levels of PM2.5 and nitrogen dioxide are independently linked to better vision—especially in younger children with mild to moderate myopia.

    5 min

  2. 07/30/2025

    Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think

    Guest: Jeffrey Walline, OD, PhD Many parents hesitate to allow young children to wear contact lenses, fearing poor hygiene or increased risk of infection. But evidence shows that kids between the ages of 7 and 12 are not at higher risk than teens; in fact, they actually have fewer complications than college-age wearers, and long-term studies reveal no difference in eye health between those fit with contact lenses in childhood versus adolescence. Here to talk about the safety of contact lenses for myopic children is Dr. Jeffrey Walline, Associate Dean of Academic Affairs at The Ohio State University College of Optometry.

  3. 07/30/2025

    Moving Beyond Correction: WCO’s Standard of Care for Myopia Management

    Guest: Ryan Quigley Myopia is more than blurred vision; it's a chronic condition requiring lifelong attention that could affect up to five billion people by 2050. In response to this growing crisis, the World Council of Optometry (WCO) has issued standard-of-care guidelines built around three pillars: Mitigation, Measurement, and Management. Tune in to learn about this evidence-based framework and how it can help you turn routine visits into proactive prevention opportunities. Reference: World Council of Optometry. The Standard of Care For Myopia Management by Optometrists. Accessed July 21, 2025. https://myopia.worldcouncilofoptometry.info/standard-of-care/

  4. 07/30/2025

    Rethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young

    Guest: Jeffrey Walline, OD, PhD Many eye care professionals and parents still believe children must wait until their teenage years to wear contact lenses, but as Dr. Jeffrey Walline explains, modern daily disposable lenses offer improved safety, comfort, and ease of use, making them a viable option for children as young as 7 or 8. And beyond the clinical benefits of slowing myopia progression and preserving long-term eye health, contact lenses have also been shown to improve children’s self-esteem. Learn more with Dr. Walline, Associate Dean of Academic Affairs at The Ohio State University College of Optometry.

  5. 10/31/2023

    A Vision for Change: Exploring Biosimilars in Retinal Disease Management

    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Arghavan Almony, MD The production of biosimilar therapies is setting the stage for a shift in how we approach treating patients with wet AMD, diabetic retinopathy, macular edema, and other retinal diseases, but many questions remain regarding how their efficacy and safety compare to the reference products and how we can best talk to our patients about these treatment options. To help shed light on these and other FAQs, Dr. Mary Katherine Cheeley speaks with Dr. Arghavan Almony, Adjunct Assistant Professor at Wallace School of Osteopathic Medicine at Campbell University in North Carolina.

  6. 05/24/2018

    Ocular Manifestations of Rheumatological Conditions

    Host: Jennifer Caudle, DO Guest: Anne Negrin, MD Since eye issues are becoming increasingly common in patients with rheumatological conditions, it’s now more vital than ever that physicians are aware of their common symptoms. Joining Dr. Jennifer Caudle is Dr. Anne Negrin, an ophthalmologist in New York, to break down these symptoms and to focus on rheumatological concerns that ophthalmologists see in practice.

  7. 04/23/2018

    FDA-Approved Gene Therapy Reverses Blindness in Children & Adults

    Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

  8. 11/25/2015

    Injectable Medication as an Alternative Treatment for Diabetic Eye Disease

    [Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina. A group of researchers from across the US tested an alternative treatment using an injectable medication called ranibizumab, to see if it would be as effective as the laser therapy. They studied more than 300 patients with PDR, assigning them to either receive standard laser therapy or an injection into the eye. In total, they treated close to 400 eyes. Outcomes, especially loss of vision, were compared at two years. Over the two year period, researchers found that patients receiving the injections of medication had fewer side effects and did somewhat better in terms of vision loss than those who received laser therapy. [Watch more videos of The JAMA Report]

See All (51)

About

Eye on Ocular Health features expert commentary on the management and prevention of debilitating eye problems, such as age-related macular degeneration, diabetic retinopathy, ocular traumas, and chronic dry eye. This series features commentary from renowned ophthalmologists discussing the most successful diagnostic and treatment options emerging in practice.

Information

  • Creator
    ReachMD
  • Years Active
    2014 - 2025
  • Episodes
    51
  • Rating
    Clean
  • Copyright
    © Copyright 2026 ReachMD. All rights reserved.
  • Show Website
    Eye on Ocular Health

More From ReachMD